Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2015 1
2016 1
2017 1
2018 5
2020 2
2021 2
2022 1
2024 2
2025 4

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

17 results

Results by year

Filters applied: . Clear all
Page 1
Induction of a mismatch repair deficient genotype by tailored chemical mutagenesis in experimental models of cancer.
Rousseau B, Patel M, Artz O, Vlachos G, Patel S, Hayatt O, Argilés G, Foote MB, Luo L, Shah R, Mehta S, Rangavajhula K, Stewart CM, Gerber D, Bhattacharya R, Stephens D, Mieles D, Randrian V, Abdelfattah S, Zhang L, Membreno-Berganza N, Lamendola-Essel MF, Piastra-Facon F, Vidal J, Johannet P, Lu S, White JR, Maron SB, Barlas A, Weipert CM, Rosiek E, Zhang T, He B, Monette S, Qu R, Fidele D, Bowker S, Kahn A, Vitiello PP, Germano G, Bardelli A, Mandal R, Ma X, Chan TA, Lu S, Cercek A, Abdel-Wahab O, de Stanchina E, Segal NH, Diaz LA Jr. Rousseau B, et al. Among authors: weipert cm. Cancer Cell. 2025 Jul 14;43(7):1313-1327.e10. doi: 10.1016/j.ccell.2025.05.010. Epub 2025 Jun 12. Cancer Cell. 2025. PMID: 40513573
CDK4/6 Inhibitor Efficacy in ESR1-Mutant Metastatic Breast Cancer.
Lloyd MR, Brett JO, Carmeli A, Weipert CM, Zhang N, Yu J, Bucheit L, Medford AJ, Wagle N, Bardia A, Wander SA. Lloyd MR, et al. Among authors: weipert cm. NEJM Evid. 2024 May;3(5):EVIDoa2300231. doi: 10.1056/EVIDoa2300231. Epub 2024 Apr 23. NEJM Evid. 2024. PMID: 38815172
A bedside-to-bench translational analysis of NF1 alterations and CDK4/6 inhibitor resistance in hormone receptor-positive metastatic breast cancer.
Lloyd MR, Chica-Parrado R, Weipert CM, Knepper TC, Podany EL, Napolitano F, Ye D, Lin CC, Uemoto Y, Liao J, Wegrzyn C, Walko CM, Ryan LY, Keenan JC, Medford AJ, Liu SA, Wulf GM, Clifton KK, Ma CX, Han HS, Zhang N, Ellisen LW, Bardia A, Arteaga CL, Hanker AB, Wander SA. Lloyd MR, et al. Among authors: weipert cm. EBioMedicine. 2025 Aug;118:105828. doi: 10.1016/j.ebiom.2025.105828. Epub 2025 Jun 27. EBioMedicine. 2025. PMID: 40578027 Free PMC article.
Serial Circulating Tumor DNA Sequencing to Monitor Response and Define Acquired Resistance to Letrozole/Abemaciclib in Endometrial Cancer.
Konstantinopoulos PA, Cai M, Lee EK, Krasner C, Campos SM, Liu JF, Horowitz NS, Shea M, Parsons HA, Wright AA, Bouberhan S, Penson RT, Yeku O, Hayes M, Sawyer H, Polak M, Castro CM, Cheng SC, Weipert CM, Matulonis UA. Konstantinopoulos PA, et al. Among authors: weipert cm. JCO Precis Oncol. 2025 Apr;9:e2400882. doi: 10.1200/PO-24-00882. Epub 2025 Apr 10. JCO Precis Oncol. 2025. PMID: 40209137 Clinical Trial.
Physician Experiences and Understanding of Genomic Sequencing in Oncology.
Weipert CM, Ryan KA, Everett JN, Yashar BM, Chinnaiyan AM, Scott Roberts J, De Vries R, Zikmund-Fisher BJ, Raymond VM. Weipert CM, et al. J Genet Couns. 2018 Feb;27(1):187-196. doi: 10.1007/s10897-017-0134-3. Epub 2017 Aug 24. J Genet Couns. 2018. PMID: 28840409 Free PMC article.
Frequency of Germline Mutations in Cancer Susceptibility Genes in Malignant Mesothelioma.
Panou V, Gadiraju M, Wolin A, Weipert CM, Skarda E, Husain AN, Patel JD, Rose B, Zhang SR, Weatherly M, Nelakuditi V, Knight Johnson A, Helgeson M, Fischer D, Desai A, Sulai N, Ritterhouse L, Røe OD, Turaga KK, Huo D, Segal J, Kadri S, Li Z, Kindler HL, Churpek JE. Panou V, et al. Among authors: weipert cm. J Clin Oncol. 2018 Oct 1;36(28):2863-2871. doi: 10.1200/JCO.2018.78.5204. Epub 2018 Aug 16. J Clin Oncol. 2018. PMID: 30113886 Free PMC article.
Prognostic tumor sequencing panels frequently identify germ line variants associated with hereditary hematopoietic malignancies.
Drazer MW, Kadri S, Sukhanova M, Patil SA, West AH, Feurstein S, Calderon DA, Jones MF, Weipert CM, Daugherty CK, Ceballos-López AA, Raca G, Lingen MW, Li Z, Segal JP, Churpek JE, Godley LA. Drazer MW, et al. Among authors: weipert cm. Blood Adv. 2018 Jan 23;2(2):146-150. doi: 10.1182/bloodadvances.2017013037. Blood Adv. 2018. PMID: 29365323 Free PMC article.
17 results